Showing results (81-90 of 282) with videos related to

Sort By:
Pageof 29
Plos One|April 2, 2013
rs12512631 on the group specific complement (vitamin D-binding protein GC) implicated in melanoma susceptibilityMaria Peña-Chilet, Maider Ibarrola-Villava, Manuel Martin-González, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Genomic loss of 18p predicts an adverse clinical outcome in patients with high-risk breast cancerJoan Climent, Jose A Martinez-Climent, David Blesa, et al.
Cancer Research|January 20, 2007
Deletion of chromosome 11q predicts response to anthracycline-based chemotherapy in early breast cancerJoan Climent, Peter Dimitrow, Jane Fridlyand, et al.
Scientific Reports|January 26, 2017
The role of miR-26a and miR-30b in HER2+ breast cancer trastuzumab resistance and regulation of the CCNE2 geneEduardo Tormo, Anna Adam-Artigues, Sandra Ballester, et al.
American Journal of Cancer Research|January 29, 2015
Methylation of tumor suppressor genes is related with copy number aberrations in breast cancerRosa Murria, Sarai Palanca, Inmaculada de Juan, et al.
Clinical Lung Cancer|December 3, 2016
Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by SurgeryMariacarmela Santarpia, Jose Luis Ramirez, Itziar de Aguirre, et al.
Familial Cancer|August 29, 2012
Low penetrance alleles as risk modifiers in familial and sporadic breast cancerEva Esteban Cardeñosa, Inmaculada de Juan Jiménez, Sarai Palanca Suela, et al.
Current Oncology (Toronto, Ont.)|January 27, 2026
SOGUG Multidisciplinary Expert Panel Consensus on Updated Diagnosis and Characterization of Prostate Cancer PatientsEnrique Gallardo, Alfonso Gómez-de-Iturriaga, Jesús Muñoz-Rodríguez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 22, 2021
Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinomaMariona Riudavets, Joaquim Bosch-Barrera, Luís Cabezón-Gutiérrez, et al.
Breast Cancer Research and Treatment|February 14, 2009
CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriersSarai Palanca Suela, Eva Esteban Cardeñosa, Eva Barragán González, et al.
Pageof 29